The findings of this study indicate that the implementation of the QIoT solution has resulted in significant improvements in various aspects of asthma management. The solution’s features have positively impacted symptom control, peak flow testing, trigger awareness, self-management behaviours, and patient education.
One notable finding is that a substantial percentage of users reported experiencing improved symptom control. Specifically, 40% of participants reported going six or more days without any asthma symptoms, while 30% reported going four or more days without symptoms. This indicates that the solution has been effective in helping patients achieve better control over their asthma symptoms.
Furthermore, the functionality to calculate daily peak flow test scores against the patient baseline number was found to be helpful by 70% of users. This feature enables users to monitor their peak flow readings and track their progress over time, providing valuable information for asthma management. By actively engaging with this feature, patients are empowered to make informed decisions regarding their asthma treatment and adjust their medication or lifestyle accordingly.
Furthermore, the findings of this study regarding extended periods without any asthma symptoms are particularly significant in terms of medication adherence and its impact on hospitalisations and deaths. Research conducted by Asthma UK in 2017 highlighted that two-thirds of all asthma deaths and emergency hospitalisations are preventable if patients were adherent to their prescribed medication. The ability of the QIoT solution to track symptom-free days and record emergency steroid medication usage provides valuable data for healthcare professionals. By accurately capturing these instances and ensuring the correct level of adherence to medication, it contributes to creating healthier patients and reducing preventable hospitalisations and deaths associated with asthma exacerbations. This further underscores the importance of digital health interventions in supporting asthma management and improving patient outcomes.
In addition, the ability to display asthma zones (green, amber, red, and red emergency) was also well-received by users. approximately 70% of participants found this feature helpful in effectively managing their asthma zones. By visually representing their current asthma status, the solution enables users to quickly assess their condition and take appropriate actions, such as adjusting medication or seeking medical assistance when necessary.
The impact on trigger awareness and self-management behaviours is another important outcome of this study. A significant majority of users (70%) reported increased awareness of asthma triggers, indicating that the solution has successfully enhanced their understanding of factors that can worsen their asthma symptoms. This newfound awareness allows patients to take proactive measures to avoid triggers and mitigate the risk of asthma exacerbations.
Moreover, the educational resources and quizzes were found to be valuable tools for patient education. A high percentage of participants (90%) agreed that the asthma control test quiz on the solution helped increase their understanding and management of their daily asthma. Similarly, 100% of participants agreed that the quiz and scoring of questions and answers were simple and effective in engaging them to think about their asthma management. This demonstrates the ability to provide educational support and empower patients to take an active role in managing their asthma.
The impact on healthcare utilisation and patient confidence is noteworthy. A significant percentage of participants (55.6%) reported visiting the doctor less during the trial period, attributing this decrease to increased confidence in their asthma management facilitated by the functionality and support. Additionally, 88.9% of participants felt more aware of when to take their inhaler, further highlighting the solution’s positive influence on medication adherence and self-management.
The features for recording and sharing daily incidents and reports were found to be valuable in clinical settings. All participants agreed that sharing the notes and reports section of the solution during asthma clinic appointments helped their healthcare professionals develop more tailored management plans. Additionally, 77.8% of participants agreed that the report section, which compiles all activity into user-friendly charts and graphs, helped them identify previously unknown triggers of their asthma. These findings emphasize the solution’s potential to facilitate communication and collaboration between patients and healthcare providers, ultimately leading to more effective asthma management.